Predictions
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.24
17.11.22
17.11.22
-
17.11.23
17.11.23
0.48%
26.12.22
26.12.22
Risky Investment
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€2.88
16.10.22
16.10.22
-
16.10.23
16.10.23
-19.44%
30.10.22
30.10.22
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€3.42
11.10.22
11.10.22
-
11.10.23
11.10.23
-15.79%
15.10.22
15.10.22
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€13.00
07.10.22
07.10.22
-
07.10.23
07.10.23
-51.15%
07.10.22
07.10.22
Euromedis Groupe
Start price
Target price
Perf. (%)
€4.10
04.10.22
04.10.22
-
04.10.23
04.10.23
14.15%
25.10.22
25.10.22
Probably not worthwhile Investment
Sienna Senior Living Inc
Start price
Target price
Perf. (%)
€9.70
19.09.22
19.09.22
€14.00
19.09.23
19.09.23
-10.31%
01.10.22
01.10.22
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.65
18.09.22
18.09.22
-
18.09.23
18.09.23
-3.77%
01.10.22
01.10.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.62
14.09.22
14.09.22
-
14.09.23
14.09.23
1.70%
17.09.22
17.09.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.00
13.09.22
13.09.22
-
13.09.23
13.09.23
-17.56%
17.09.22
17.09.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.62
13.09.22
13.09.22
-
13.09.23
13.09.23
-37.10%
17.09.22
17.09.22
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.91
13.08.22
13.08.22
€1.00
13.08.23
13.08.23
-12.70%
23.08.22
23.08.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Tabula Rasa HealthCare Inc
Start price
Target price
Perf. (%)
€4.02
21.07.22
21.07.22
-
21.07.23
21.07.23
0.50%
23.07.22
23.07.22
Pulse Biosciences Inc
Start price
Target price
Perf. (%)
€1.74
12.07.22
12.07.22
€6.00
12.07.23
12.07.23
259.20%
13.07.23
13.07.23
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.24
24.06.22
24.06.22
€5.00
24.06.23
24.06.23
-1.57%
26.06.22
26.06.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.77
10.06.22
10.06.22
€0.20
10.06.23
10.06.23
24.58%
26.06.22
26.06.22
Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.24
29.05.22
29.05.22
-
29.05.23
29.05.23
71.13%
09.06.22
09.06.22
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.29
01.05.22
01.05.22
-
01.05.23
01.05.23
-2.33%
14.05.22
14.05.22
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.59
18.04.22
18.04.22
-
18.04.23
18.04.23
-18.84%
30.04.22
30.04.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.23
06.04.22
06.04.22
-
06.04.23
06.04.23
-28.56%
18.04.22
18.04.22
Could be very worthwhile Investment >20% year
Pulse Biosciences Inc
Start price
Target price
Perf. (%)
€3.16
02.04.22
02.04.22
€2.00
02.04.23
02.04.23
-1.90%
16.04.22
16.04.22
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€7.59
01.04.22
01.04.22
€12.50
01.04.23
01.04.23
-76.56%
04.03.23
04.03.23
Could be worthwhile Investment >10% per year